Want to see CLB full AI Analyst Report?
CLB Stock Chart & Stats
$11.23
-$0.44(-3.77%)
At close: 4:00 PM EDT
$11.23
-$0.44(-3.77%)
Day’s Range― - ―
52-Week Range$9.72 - $20.36
Previous Close$11.23
Volume609.49K
Average Volume (3M)411.26K
Market Cap
$488.21M
Enterprise Value$688.51
Total Cash (Recent Filing)$22.73M
Total Debt (Recent Filing)$39.31M
Price to Earnings (P/E)19.0
Beta1.20
Next Earnings
Oct 28, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend Yield0.38%
Share Statistics
EPS (TTM)0.56
Shares Outstanding45,884,540
10 Day Avg. Volume423,711
30 Day Avg. Volume411,263
Financial Highlights & Ratios
PEG Ratio15.79
Price to Book (P/B)2.80
Price to Sales (P/S)1.42
P/FCF Ratio33.44
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$11.00Price Target Upside-2.05% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)0.47
Revenue Forecast (FY)$513.14M
Bulls Say, Bears Say
Bulls Say
Geopolitical TensionsPotential easing of geopolitical tensions between Russia and Ukraine could serve as a positive catalyst for the company.
Research And DevelopmentThe Research and Development division is expected to grow, likely outpacing international upstream capital expenditure growth.
Bears Say
Production Enhancement ChallengesProduction Enhancement has shrunk to just 11% of total company operating income, indicating challenges in that segment.
Core Laboratories News
CLB FAQ
What was Core Laboratories N.V.’s price range in the past 12 months?
Core Laboratories N.V. lowest stock price was $9.72 and its highest was $20.36 in the past 12 months.
What is Core Laboratories N.V.’s market cap?
Core Laboratories N.V.’s market cap is $488.21M.
When is Core Laboratories N.V.’s upcoming earnings report date?
Core Laboratories N.V.’s upcoming earnings report date is Oct 28, 2026 which is in 86 days.
How were Core Laboratories N.V.’s earnings last quarter?
Core Laboratories N.V. released its earnings results on Jul 29, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.087 by $0.023.
Is Core Laboratories N.V. overvalued?
According to Wall Street analysts Core Laboratories N.V.’s price is currently Overvalued.
Does Core Laboratories N.V. pay dividends?
Core Laboratories N.V. pays a Quarterly dividend of $0.01 which represents an annual dividend yield of 0.38%. See more information on Core Laboratories N.V. dividends here
What is Core Laboratories N.V.’s EPS estimate?
Core Laboratories N.V.’s EPS estimate is 0.16.
How many shares outstanding does Core Laboratories N.V. have?
Core Laboratories N.V. has 45,884,540 shares outstanding.
What happened to Core Laboratories N.V.’s price movement after its last earnings report?
Core Laboratories N.V. reported an EPS of $0.11 in its last earnings report, beating expectations of $0.087. Following the earnings report the stock price went up 4.863%.
Which hedge fund is a major shareholder of Core Laboratories N.V.?
Currently, no hedge funds are holding shares in CLB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Core Laboratories Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$11.00 (-2.05% Downside)
$11.00 (-2.05% Downside)
Blogger Sentiment
Bullish
CLB Sentiment 66%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 931.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.24%
12-Months-Change
Fundamentals
Return on Equity
0.38%
Trailing 12-Months
Asset Growth
-0.64%
Trailing 12-Months
Company Description
Core Laboratories N.V.
Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
CLB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted clear sequential improvements in revenue, margins, product sales, and operating profitability, a constructive Q3 outlook, continued technology commercialization and disciplined capital returns. However, year-over-year revenue and earnings declined, with significant near-term headwinds from geopolitical conflicts (Middle East and Russia/Ukraine) adversely affecting assay and service work and forcing ongoing cost carry and regional operating challenges. Management emphasizes operational resilience, technology adoption, and shareholder returns while guiding for sequential growth into Q3.View all CLB earnings summariesCLB Stock 12 Month Forecast
Average Price Target
$11.00
▼(-2.05% Downside)
Technical Analysis
Flotek
―
Oil States International
―
Tetra Technologies
―
Propetro Holding
―
ProFrac Holding
―
Ownership Overview
1.10% Insiders
33.45% Mutual Funds
0.34% Other Institutional Investors
49.27% Public Companies and
Individual Investors







